DUBLIN--(BUSINESS WIRE)--Mar. 26, 2012--
plc (NYSE: COV) will report second-quarter results on April 27, 2012,
before trading begins. The Company will hold a conference call for
investors at 8:30 a.m. ET. The call can be accessed in the following
At Covidien’s website: http://investor.covidien.com
By telephone: For both “listen-only” participants and those
participants who wish to take part in the question-and-answer portion
of the call, the telephone dial-in number in the U.S. is 866-825-1709.
For participants outside the U.S., the dial-in number is 617-213-8060.
The access code for all callers is 95914121.
Through an audio replay: A replay of the conference call will be
available beginning at 11:30 a.m. on April 27, 2012, and ending at
5:00 p.m. on May 4, 2012. The dial-in number for U.S. participants is
888-286-8010. For participants outside the U.S., the replay dial-in
number is 617-801-6888. The replay access code for all callers is
Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers
value through clinical leadership and excellence. Covidien manufactures,
distributes and services a diverse range of industry-leading product
lines in three segments: Medical Devices, Pharmaceuticals and Medical
Supplies. With 2011 revenue of $11.6 billion, Covidien has 41,000
employees worldwide in more than 65 countries, and its products are sold
in over 140 countries. Please visit www.covidien.com
to learn more about our business.
Eric Kraus, 508-261-8305
Senior Vice President
Lannum, CFA, 508-452-4343